Profile
ATP Fund is an early-stage venture catalyst based in the United States focusing on empowering scientific visionaries to solve humanity’s grand challenges for a sustainable future. Founded by a team with over 24 years of venture experience, the firm possesses a significant track record of successful investments and collaboration with scientific innovators. Their team consists of managing partner Kyle Cox, partner Bart Bohn, and other key members like John Stockton and Brian Huskinson, PhD, bringing together a wealth of expertise and industry connections.
ATP Fund primarily targets sectors such as health and therapeutics, energy transition, and enterprise sustainability—specifically focusing on adaptations involving machine learning, AI, quantum computing, and blockchain technologies. They are known for supporting ventures through their Proto.n program and have demonstrated considerable success with $35 billion in exits from 35 companies, including two IPOs and 13 M&A deals. Their investment stages are pre-seed, seed, and Series A with ticket sizes ranging from $0 to $5 million.
Notable companies in ATP Fund’s portfolio include businesses harnessing AI for improved outcomes in health and adaptive infrastructure strategies and those contributing solutions for enhanced enterprise management across underserved ecosystems. Their expertise and proactive approach ensure noteworthy results for both innovators and investors.
Industry
Contacts
Instant access on the web. Plans from $129/month — see pricing.